Serge Ferrari

Serge Ferrari is Full Professor at the University of Geneva's Faculty of Medicine, where he serves as Vice-Dean for Translational Research and Development. He concurrently heads the Division of Bone Diseases at Geneva University Hospitals (HUG) and directs the Bone Diseases Research Laboratory. His academic trajectory includes an MD from Geneva (1991), internal medicine specialization (1997), a research fellowship at Harvard Medical School (1997-2001), and progressive appointments culminating in his full professorship in 2014. From 2019-2023, he was Academic Director of the Department of Medicine.

His research explores biological mechanisms of bone remodeling and therapeutic targets for bone fragility, with continuous SNSF funding for over 20 years. Primary interests include osteoporosis pathophysiology, genetic determinants of bone strength, and translational applications in metabolic bone diseases. Current work emphasizes diabetes-related skeletal fragility and optimization of anti-osteoporosis drug sequences.

Analysis of 15 recent publications (2025-2024) reveals dominant themes: osteoporosis pharmacotherapy (romosozumab, denosumab), fracture risk modeling, diabetic bone disease, and treatment guidelines. Articles frequently utilize advanced metrics like trabecular bone score (TBS) and 3D bone modeling, reflecting methodological innovation in assessing skeletal health.

Scientific Awards:

• SNSF Professorship (2001)

He leads the Bone Diseases Research Laboratory and Osteoporosis Genetics Research Group, fostering collaborations across translational research pipelines. As Vice-Chairman of the International Osteoporosis Foundation Scientific Council (2016-2024) and former President of the Swiss Osteoporosis Association, he shapes global osteoporosis management strategies. His editorial leadership includes former roles at BoneKey and BoneKey Reports.